Seth Karp
Last active: 4/11/2016

Successful DCD kidney transplantation using early corticosteroid withdrawal.

Chudzinski RE, Khwaja K, Teune P, Miller J, Tang H, Pavlakis M, Rogers C, Johnson S, Karp S, Hanto D, Mandelbrot D
Am J Transplant. 2010 10 (1): 115-23

PMID: 19958332 · DOI:10.1111/j.1600-6143.2009.02922.x

Organs from donors after cardiac death (DCD) are being increasingly utilized. Prior reports of DCD kidney transplantation involve the use of prednisone-based immunosuppression. We report our experience with early corticosteroid withdrawal (ECSW). Data on 63 DCD kidney transplants performed between 2002 and 2007 were analyzed. We compared outcomes in 28 recipients maintained on long-term corticosteroids (LTCSs) with 35 recipients that underwent ECSW. DGF occurred in 49% of patients on ECSW and 46% on LTCS (p=0.8). There was no difference between groups for serum creatinine or estimated GFR between 1 and 36 months posttransplant. Acute rejection rates at 1 year were 11.4% and 21.4% for the ECSW and LTCS group (p=0.2). Graft survival at 1 and 3 years was 94% and 91% for the ECSW group versus 82% and 78% for the LTCS group (p>or=0.1). Death censored graft survival was significantly better at last follow-up for the ECSW group (p=0.02). Multivariate analysis revealed no correlation between the use of corticosteroids and survival outcomes. In conclusion, ECSW can be used successfully in DCD kidney transplantation with no worse outcomes in DGF, rejection, graft loss or the combined outcome of death and graft loss compared to patients receiving LTCS.

MeSH Terms (18)

Adrenal Cortex Hormones Adult Cadaver Creatinine Death Female Glomerular Filtration Rate Graft Rejection Graft Survival Humans Immunosuppressive Agents Kidney Transplantation Male Middle Aged Retrospective Studies Time Factors Tissue Donors Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities:

Links